Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Golden Gate Ventures is a Singapore-headquartered early-stage venture capital firm focused primarily on technology startups across Southeast Asia and, more recently, other emerging markets. Founded in 2011, the firm positions itself as a global venture platform with local operating presence in Singapore, Indonesia, Vietnam, and expansion into MENA. It is not a biotech, pharma, or healthcare operating company; rather, it invests across multiple sectors, including occasional healthtech and biotech opportunities within its portfolio. The firm has launched multiple funds and reports substantial assets under management, with a portfolio spanning dozens of startups and several unicorns. For a biotech analyst, Golden Gate Ventures is best understood as an investor in innovation ecosystems rather than a developer of therapeutics, diagnostics, or medical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Golden Gate Ventures.